Showing 1 - 7 results of 7 for search 'Dong-Sheng Chen', query time: 0.04s Refine Results
  1. 1
    Case Report: Adjuvant Crizotinib Therapy Exerted Favorable Survival Benefit in a Resectable Stage IIIA NSCLC Patient With Novel LDLR–ROS1 Fusion

    Case Report: Adjuvant Crizotinib Therapy Exerted Favorable Survival Benefit in a Resectable Stage IIIA NSCLC Patient With Novel LDLR–ROS1 Fusion by An-guo Chen, Dong-sheng Chen, Dong-sheng Chen, Dong-sheng Chen, Si Li, Si Li, Si Li, Le-le Zhao, Le-le Zhao, Le-le Zhao, Ming-zhe Xiao, Ming-zhe Xiao, Ming-zhe Xiao

    Published 2022-03-01
    Get full text
    Article
  2. 2
    Research on Control Strategies of an Open-End Winding Permanent Magnet Synchronous Driving Motor (OW-PMSM)-Equipped Dual Inverter with a Switchable Winding Mode for Electric Vehicles

    Research on Control Strategies of an Open-End Winding Permanent Magnet Synchronous Driving Motor (OW-PMSM)-Equipped Dual Inverter with a Switchable Winding Mode for Electric Vehicl... by Liang Chu, Yi-fan Jia, Dong-sheng Chen, Nan Xu, Yan-wei Wang, Xin Tang, Zhe Xu

    Published 2017-05-01
    Get full text
    Article
  3. 3
    Pseudorabies virus infected porcine epithelial cell line generates a diverse set of host microRNAs and a special cluster of viral microRNAs.

    Pseudorabies virus infected porcine epithelial cell line generates a diverse set of host microRNAs and a special cluster of viral microRNAs. by Yi-Quan Wu, Di-Jun Chen, Hua-Bin He, Dong-Sheng Chen, Ling-Ling Chen, Huan-Chun Chen, Zheng-Fei Liu

    Published 2012-01-01
    Get full text
    Article
  4. 4
    Immune-related RNA signature predicts outcome of PD-1 inhibitor-combined GEMCIS therapy in advanced intrahepatic cholangiocarcinoma

    Immune-related RNA signature predicts outcome of PD-1 inhibitor-combined GEMCIS therapy in advanced intrahepatic cholangiocarcinoma by Tian-mei Zeng, Tian-mei Zeng, Yu-fei Pan, Zhen-gang Yuan, Dong-sheng Chen, Yun-jie Song, Yong Gao, Yong Gao

    Published 2022-09-01
    Get full text
    Article
  5. 5
    HPV16 integration probably contributes to cervical oncogenesis through interrupting tumor suppressor genes and inducing chromosome instability

    HPV16 integration probably contributes to cervical oncogenesis through interrupting tumor suppressor genes and inducing chromosome instability by Jun-Wei Zhao, Fang Fang, Yi Guo, Tai-Lin Zhu, Yun-Yun Yu, Fan-Fei Kong, Ling-Fei Han, Dong-Sheng Chen, Fang Li

    Published 2016-11-01
    Get full text
    Article
  6. 6
    NOTCH1 mutation associates with impaired immune response and decreased relapse-free survival in patients with resected T1-2N0 laryngeal cancer

    NOTCH1 mutation associates with impaired immune response and decreased relapse-free survival in patients with resected T1-2N0 laryngeal cancer by Xiao-yang Gong, Hai-bin Chen, Li-qing Zhang, Dong-sheng Chen, Wang Li, Dong-hui Chen, Jin Xu, Han Zhou, Le-le Zhao, Yun-jie Song, Ming-zhe Xiao, Wang-long Deng, Chuang Qi, Xue-rong Wang, Xi Chen

    Published 2022-07-01
    Get full text
    Article
  7. 7
    Clinical and biomarker analyses of sintilimab plus gemcitabine and cisplatin as first-line treatment for patients with advanced biliary tract cancer

    Clinical and biomarker analyses of sintilimab plus gemcitabine and cisplatin as first-line treatment for patients with advanced biliary tract cancer by Tian-mei Zeng, Guang Yang, Cheng Lou, Wei Wei, Chen-jie Tao, Xi-yun Chen, Qin Han, Zhuo Cheng, Pei-pei Shang, Yu-long Dong, He-ming Xu, Lie-ping Guo, Dong-sheng Chen, Yun-jie Song, Chuang Qi, Wang-long Deng, Zhen-gang Yuan

    Published 2023-03-01
    Get full text
    Article

Search Tools: